Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma

被引：0
|
作者：
Ahmad Joshkon
Emeline Tabouret
Wael Traboulsi
Richard Bachelier
Stéphanie Simoncini
Sandrine Roffino
Carine Jiguet-Jiglaire
Bassam Badran
Benjamin Guillet
Alexandrine Foucault-Bertaud
Aurelie S. Leroyer
Françoise Dignat-George
Olivier Chinot
Hussein Fayyad-Kazan
Nathalie Bardin
Marcel Blot-Chabaud
机构：
[1] Aix-Marseille University,Department of Neuro
[2] INSERM1263,Oncology
[3] INRAE1260,Laboratory of Cancer Biology and Molecular Immunology, Faculty of Science
[4] C2VN,Department of Radiopharmacy
[5] Aix-Marseille University,undefined
[6] APHM,undefined
[7] CNRS,undefined
[8] INP,undefined
[9] Service de Neuro-Oncologie CHU Timone,undefined
[10] Hôpitaux de Marseille,undefined
[11] CNRS,undefined
[12] ISM UMR 7287,undefined
[13] Aix-Marseille University,undefined
[14] Lebanese University,undefined
[15] La Timone University Hospital,undefined
[16] CERIMED,undefined
[17] Aix-Marseille University,undefined
来源：
Acta Neuropathologica Communications | / 10卷
关键词：
Soluble CD146; Biomarker; Therapeutic antibody; Bevacizumab; Glioblastoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [41] Target-based Anti-angiogenic Therapy in Breast Cancer
    Wehland, Markus
    Bauer, Johann
    Infanger, Manfred
    Grimm, Daniela
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (27) : 4244 - 4257
  • [42] Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
    Comunanza, Valentina
    Bussolino, Federico
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2017, 5
  • [43] Pleiotrophin as a Novel Target for Anti-Angiogenic Therapy of Diabetic Retinopathy
    Wang, Weiwen
    LeBlanc, Michelle Elizabeth
    Chen, Xiuping
    Ji, Yanli
    Brewer, Megan
    Gonzalez, Vivianne
    Li, Wei
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [44] Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia
    Harhouri, Karim
    Kebir, Abdeldjalil
    Guillet, Benjamin
    Foucault-Bertaud, Alexandrine
    Voytenko, Serge
    Piercecchi-Marti, Marie-Dominique
    Berenguer, Caroline
    Lamy, Edouard
    Vely, Frederic
    Pisano, Pascale
    Ouafik, L'Houcine
    Sabatier, Florence
    Sampol, Jose
    Bardin, Nathalie
    Dignat-George, Francoise
    Blot-Chabaud, Marcel
    BLOOD, 2010, 115 (18) : 3843 - 3851
  • [45] A NOVEL XENOGRAFT MODEL REVEALS A GENE CASCADE AND SERUM BIOMARKER DEFINING A MESENCHYMAL TRANSITION DURING THE EVOLUTION OF GLIOBLASTOMA RESISTANCE TO ANTI-ANGIOGENIC THERAPY
    Jahangiri, Arman
    Chen, William
    Nguyen, Alan
    Rick, Jonathan
    Kuang, Ruby
    Sidorov, Maxim
    Flanigan, Patrick M.
    Wagner, Jeffrey R.
    Carbonell, W. Shawn
    Yagnik, Garima
    Aghi, Manish K.
    NEURO-ONCOLOGY, 2017, 19 : 65 - 65
  • [46] Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization
    Bouvier, Sylvie
    Paulmyer-Lacroix, Odile
    Molinari, Nicolas
    Bertaud, Alexandrine
    Paci, Marine
    Leroyer, Aurelie
    Robert, Stephane
    George, Francoise Dignat
    Blot-Chabaud, Marcel
    Bardin, Nathalie
    PLOS ONE, 2017, 12 (03):
  • [47] Fibrocytes As A Possible Cellular Biomarker For Anti-Angiogenic Therapy In Lung Cancer
    Goto, H.
    Mitsuhashi, A.
    Saijo, A.
    Ogino, H.
    Otsuka, K.
    Tobiume, M.
    Yoneda, H.
    Hanibuchi, M.
    Nishioka, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [48] Soluble CD146 as a Potential Target for Preventing Triple Negative Breast Cancer MDA-MB-231 Cell Growth and Dissemination
    Sharma, Akshita
    Joshkon, Ahmad
    Ladjimi, Aymen
    Traboulsi, Wael
    Bachelier, Richard
    Robert, Stephane
    Foucault-Bertaud, Alexandrine
    Leroyer, Aurelie S.
    Bardin, Nathalie
    Somasundaram, Indumathi
    Blot-Chabaud, Marcel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [49] Nestin as a novel angiogenic marker and target for anti-angiogenic therapy in human pancreatic cancer
    Yamahatsu, Kazuya
    Matsuda, Yoko
    Yamamoto, Tetsushi
    Aimoto, Takayuki
    Nakamura, Yoshiharu
    Hiroi, Makoto
    Uchida, Eiji
    Naito, Zenya
    Ishiwata, Toshiyuki
    CANCER RESEARCH, 2011, 71
  • [50] Vessel co-option and resistance to anti-angiogenic therapy
    Kuczynski, Elizabeth A.
    Reynolds, Andrew R.
    ANGIOGENESIS, 2020, 23 (01) : 55 - 74
12345